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Abstract: Celiac disease (CeD) is a complex immune-mediated inflammatory condition triggered by
the ingestion of gluten in genetically predisposed individuals. Literature suggests that alterations in
gut microbiota composition and function precede the onset of CeD. Considering that microbiota is
partly determined by host genetics, we speculated that the genetic makeup of CeD patients could elicit
disease development through alterations in the intestinal microbiota. To evaluate potential causal
relationships between gut microbiota and CeD, we performed a two-sample Mendelian randomization
analysis (2SMR). Exposure data were obtained from the raw results of a previous genome-wide
association study (GWAS) of gut microbiota and outcome data from summary statistics of CeD GWAS
and Immunochip studies. We identified a number of putative associations between gut microbiota
single nucleotide polymorphisms (SNPs) associated with CeD. Regarding bacterial composition,
most of the associated SNPs were related to Firmicutes phylum, whose relative abundance has been
previously reported to be altered in CeD patients. In terms of functional units, we linked a number of
SNPs to several bacterial metabolic pathways that seemed to be related to CeD. Overall, this study
represented the first 2SMR approach to elucidate the relationship between microbiome and CeD.
Keywords: celiac disease; gut microbiota; Mendelian randomization
1. Introduction
Celiac disease (CeD), the most common food intolerance, is a chronic immune-mediated systemic
disorder triggered by an aberrant immune response to dietary gluten in genetically predisposed
individuals [1]. Virtually all CeD cases harbor specific genetic variants located in the human leukocyte
antigen (HLA) region that encode for the HLA-DQ2/DQ8 heterodimers capable of presenting gluten
peptides to T-cells, thus activating an inflammatory immune response in the intestine [2]. In addition to
HLA risk alleles, genome-wide association studies (GWAS) have identified more than 40 non-HLA loci
with modest contributions to CeD risk [3,4]. Whereas genetic predisposition and gluten exposure are
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necessary, they seem to be insufficient for the development of CeD, suggesting that other factors might
serve as crucial triggers for disease onset and progression. Gut microbiota could be one such factor.
The human gut microbiota is composed of the microbial communities, mainly bacteria, which
live in the digestive tract. It is acquired at birth from the environment, and diversity builds up
over the first few years of life [5,6]. Afterwards, the composition of the gut microbiota is largely
shaped not only by environmental factors, such as diet [7], but also by host genetic components [8–10].
Studies carried out in twins support the idea that host genetics influences gut microbial diversity [11].
Specific genetic variations have been linked to a vast array of medical conditions [12], including
CeD. Cross-sectional studies indicate that the composition of the gut microbiota is altered in subjects
with CeD compared with controls [13–16]. Prospective studies performed so far report differences
in microbiota composition and diversity between children with a genetic predisposition for CeD
compared to those with a non-selected genetic background [17–20]. Considering that host genetics
contributes to the composition and function of gut microbiota, it is feasible to think that risk genotypes
for CeD act in part via the microbiota. However, the limited number of studies carried out in patients,
together with the small sample sizes, make it difficult to mechanistically correlate host genetics, gut
microbiota, and CeD.
Mendelian randomization (MR) is an increasingly used statistical tool that can help establish a
causal relationship between an exposure and an outcome of interest by employing single nucleotide
polymorphisms (SNPs) as instrumental variables [21]. Two-sample Mendelian randomization (2SMR)
refers to the application of MR in non-overlapping sets of individuals. These data can be obtained
from public summary statistics of GWAS or estimated directly from own genomic datasets [22].
Landmark genomic studies have identified many SNPs associated with gut microbiota structure and
function [8–10], which could serve as valid instruments for the exposure in 2SMR analyses. Regarding
outcomes of interest, SNPs could be selected from relevant GWAS on CeD [4]. Thus, it is possible
to investigate how gut microbiota composition and function may affect CeD risk by using publicly
available data.
This study represented the first 2SMR approach to examine the interplay between host genetics,
gut microbiota, and CeD. Our analysis identified a number of genetic variants associated with
bacterial composition and function that could be driving CeD pathogenesis. These findings not only
improve our understanding of the disease but also elicit new research lines towards diagnosis and
clinical management.
2. Materials and Methods
Two-sample MR analysis was conducted using the “TwoSampleMR” R package [23], following
the guidelines provided by the developers (https://mrcieu.github.io/TwoSampleMR), and in-house
developed R scripts (available upon request). Figure 1a displays a flowchart describing the
whole procedure.
2.1. Preparation of Exposure Data
Genetic instruments from the exposure data were obtained from the raw results of the microbiome
GWAS carried out by Bonder and colleagues in 1514 subjects [10]. Raw data comprised three
independent datasets associating genetic variants (SNPs) with different bacterial traits, namely,
taxonomies (taxa), MetaCyc pathways (pathway), and gene ontology (GO) terms. Bacterial taxonomies
included information about phyla, classes, orders, families, genera, and species. MetaCyc pathways
referred to experimentally elucidated metabolic pathways from bacteria retrieved from the MetaCyc
metabolic pathway database (https://metacyc.org), while GO-terms comprised a subset of ‘informative’
GO terms, associated with more than 2000 proteins for which no descendant term was associated.
A more detailed description is available in the original article from Bonder and collaborators [10].
We filtered the three SNP sets by p-value and further investigated only those showing suggestive
associations using an empirical significance level (p < 10−5).
Nutrients 2020, 12, 1420 3 of 10
Nutrients 2020, 12, x FOR PEER REVIEW 3 of 12 
 
This study represented the first 2SMR approach to examine the interplay 
between host genetics, gut microbiota, and CeD. Our analysis identified a number 
of genetic variants associated with bacterial composition and function that could be 
driving CeD pathogenesis. These findings not only improve our understanding of 
the disease but also elicit new research lines towards diagnosis and clinical 
management.  
2. Materials and Methods  
Two-sample MR analysis was conducted using the “TwoSampleMR” R package 
[23], following the guidelines provided by the developers 
(https://mrcieu.github.io/TwoSampleMR), and in-house developed R scripts 
(available upon request). Figure 1a displays a flowchart describing the whole 
procedure.  
 
Figure 1. Schematic representation of two-sample Mendelian randomization analysis (2SMR) using 
Bonder microbiome and Dubois celiac disease (CeD) genome-wide association study (GWAS) as 
exposure and outcome datasets, respectively. (a) Flowchart of the step-by-step analysis: after 
preparing exposure data (Step 1), outcome data is extracted (Step 2), both datasets are harmonized 
(Step 3), and 2SMR analysis is performed (Step 4); finally, significant hits are selected based on their 
false discovery rate (FDR) (Step 5); (b) Diagram, representing the number of single nucleotide 
polymorphisms (SNPs) selected in each category (taxa, pathway, gene ontology (GO)) after 
performing each step of the analysis. 
2.1. Preparation of Exposure Data 
Genetic instruments from the exposure data were obtained from the raw results 
of the microbiome GWAS carried out by Bonder and colleagues in 1514 subjects [10]. 
Raw data comprised three independent datasets associating genetic variants (SNPs) 
with different bacterial traits, namely, taxonomies (taxa), MetaCyc pathways 
(pathway), and gene ontology (GO) terms. Bacterial taxonomies included 
information about phyla, classes, orders, families, genera, and species. MetaCyc 
pathways referred to experimentally elucidated metabolic pathways from bacteria 
113 314 SNPs
5 SNPs
6 756 SNPs
2 232 SNPs
2 232 SNPs
1 970 SNPs
226 529 SNPs
238 577 SNPs
9 139 SNPs
2 865 SNPs
2 865 SNPs
2 527 SNPs
328 759 SNPs
254 205 SNPs
9 137 SNPs
2 796 SNPs
2 796 SNPs
2 462 SNPs
405 693 SNPs
3 SNPs 1 SNP
taxa pathway GO
1. Preparation of exposure data (Microbiome)
1.1. Select instruments (SNPs)
1.2. Perform LD clumping
2. Preparation of outcome data (CeD, Dubois)
Extract the instruments from the IEU GWAS 
database
3. Data harmonization (Microbiome & CeD)
Harmonize the effect sizes for the instruments 
on the exposure / outcome
4. 2SMR analysis
Using harmonized data, estimate the causal 
effect of microbiome on CeD
5. Selection of significant hits
Filter 2SMR results to include those with FDR 
< 0,05
5 5 5
4 4 4
3 3 3
2 2 2
1.2 1.2 1.2
1.1 1.1 1.1
a b
Figure 1. Schematic representation of two-sample endelian randomization analysis (2SMR) using
Bonder microbiome and Dubois celiac disease ( ) nome-wide association study (GWAS) as
exposure and outcome datasets, respectively. (a) Flowchart of the step-by-step analysis: after preparing
exposure data (Step 1), outcome data is extracted (S ep 2), both datasets are harmonized (Step 3),
and 2SMR analysis is performed (Step 4); finally, significant hits are selected based on their false
discovery rate (FDR) (Step 5); (b) Diagram, representing the number of single nucleotide polymorphisms
(SNPs) selected in each category (taxa, pathway, gene ontology (GO)) after performing each step of
the analysis.
Next, datasets were converted to the “exposure data” format using the format_data function of
the TwoSampleMR package. In this process, SNPs that did not have the standard “rs” nomenclature
(less than 0.02% of all the variants) were dropped. In the case of SNPs that appeared more than once
(due to association with more than one bacterial trait), only the one with the lowest p-value was retained.
Once exposure data had been formatted, independent SNPs were selected with the clump_data
function in the same package, which used the 1000 genomes project as a reference panel. Stringent
clumping criteria were set to retain only those SNPs with the lowest p-value above a linkage
disequilibrium (LD) threshold of r2 = 0.01 in 10,000 Kb windows.
2.2. Preparation of Outcome Data
Summary-level data of two independent association studies on CeD were retrieved from the IEU
GWAS database. As a discovery dataset, we selected the largest-to-date GWAS on CeD, published
by Dubois and colleagues in 2010 (ebi-a-GCST-000612). In this work, more than 500,000 SNPs
were genotyped in 4533 CeD individuals and 10,750 controls [4]. As a replication dataset, we used
the celiac Immunochip study, performed by Trynka and collaborators (ebi-a-GCST005523) in 2011.
The investigators carried out a dense-genotyping of immune-mediated disease loci in 12,041 CeD
subjects and 12,228 controls, mapping in-depth previously identified GWAS peaks and discovering
several new CeD-associated regions [3]. Instrument SNPs from the GWAS and Immunochip results
were obtained and formatted with the extract_outcome_data function, using previously prepared
exposure data as input.
2.3. Harmonization of Exposure and Outcome Data
To ensure that the effect of an SNP on the exposure and on the outcome corresponds to the same
allele, both exposure and outcome datasets were harmonized using the harmonise_data function. In this
process, ambiguous and/or palindromic SNPs were removed, creating a new data frame that had the
exposure and outcome data combined.
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2.4. Two-Sample Mendelian Randomization (2SMR) and Statistical Analysis
2SMR analysis was performed on the harmonized data frame using the mr() function, which
returned a data frame of estimates of the causal effect of the exposure on the outcome for a range
of different MR methods (Wald ratio, MR Egger, weighted median, inverse variance weighted,
and weighted mode). The multiple-testing-adjusted p-value, (false discovery rate, FDR) was calculated
with the Benjamini–Hochberg procedure with the function p.adjust() of the “stats” package in R.
3. Results
Using a 2SMR approach, we set out to identify associations between gut microbiota (exposure)
and CeD (outcome) using genetic variants. Exposure data were obtained from raw results of one
of the most complete GWAS on the gut microbiome, where Bonder and colleagues examined the
influence of host genetics on gut microbiota composition (by interrogating microbial taxonomies) and
function (by assessing bacterial MetaCyc pathways and GO-terms) [10]. These data were used to
prepare three exposure datasets: taxa, pathway, and GO, for our 2SMR analysis. After a stringent
selection procedure of genetic variants (see Materials and Methods section for details), we retained
6756, 9179, and 9137 SNPs in taxa, pathway, and GO categories, respectively (Figure 1b). Outcome
data was prepared using summary-level data from the to-date largest CeD GWAS, which included
genetic variants encompassing the whole genome [4]. This led to the selection of 2232, 2865, and 2796
SNPs in the taxa, pathway, and GO categories, respectively, which were subsequently harmonized
and finally analyzed with 2SMR. We selected SNPs with an FDR < 0.05, identifying 5, 6, and 1 hits
associated with the taxa, pathway, and GO categories, respectively (Table 1).
Table 1. Two-sample Mendelian randomization estimates between the gut microbiota and CeD.
SNP Effect/Other Alleles Chr. Position p-Value Effect size ± SE FDR
taxa
rs4396302 A/G 11 128420926 7.88 × 10−7 0.80 ± 0.16 0.001
rs7594065 T/C 2 204814676 1.29 × 10−6 −0.61 ± 0.13 0.001
rs10093096 C/T 8 64907701 3.56 × 10−5 −0.84 ± 0.20 0.027
rs11545016 T/C 8 22438313 6.58 × 10−5 −0.96 ± 0.24 0.037
rs12913063 T/C 15 75424593 9.97 × 10−5 1.09 ± 0.28 0.044
pathway
rs7585642 A/C 2 61217542 2.56 × 10−7 −0.92 ± 0.18 0.001
rs131659 G/A 22 21964761 4.07 × 10−5 1.04 ± 0.25 0.046
rs11867190 A/G 17 5261220 4.82 × 10−5 0.59 ± 0.14 0.046
GO
rs6848139 C/A 4 123395041 7.42 × 10−6 −1.95 ± 0.43 0.021
Chr.: Chromosome; SE: Standard error; FDR: False discovery rate.
To validate our results, we replicated the 2SMR analysis following the same criteria with the celiac
Immunochip results [3] as outcome data (Figure S1a,b). Since this study performed a dense genotyping
of specific regions of the genome (including the HLA, the main CeD-predisposing locus), the number
of SNPs finally analyzed, in this case, was around 10 times smaller, and the overlap with the SNPs
included in Dubois analysis was low (Figure S1c). Even with this small overlap, eight out of the nine
significant SNPs from the discovery study were replicated in the analysis with the Immunochip data,
and many of them showed suggestive associations at a genome-wide significance level (p < 10−5).
Of note, the differences in p-values obtained in some of the hits were due to the different significance
levels of those SNPs in the original CeD datasets used as outcome data. More importantly, forest
plots comparing the beta values from both 2SMR analyses showed similar effect sizes and directions
(Figure 2). Consistency in the results across the two independent 2SMR analyses built confidence in
the obtained estimates.
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Figure 2. Forest plots, comparing effect-sizes and p-values of SNPs identified in taxa, pathway, and GO
categories, in two independent 2SMR analyses where either Dubois or Trynka CeD datasets were used
as outcome data.
The majority of the SNPs identified were located in introns and intergenic regions of CeD-related
genes, and each of them was associated with one microbiome feature, either structural (taxa) or
functional (pathway or GO) (Table 2). Traits related to bacterial composition were mainly linked to the
Clostridiales order, a group of bacteria that have been observed to be altered in CeD individuals [24–26].
These data supported the link between the genetic variants and CeD through the modulation of gut
microbiota diversity. Regarding functional units, associated bacterial pathways and GO-terms were
related to the metabolism of certain amino acids or their derivatives, supporting the implication of
microbial metabolism on CeD pathogenesis.
Table 2. Associated microbiota traits of 2SMR hits.
SNP Associated Microbiota Trait
taxa
rs4396302 Firmicutes (p), Clostridia (c), Clostridiales (o), Peptostreptococcaceae (f ),Peptostreptococcaceae (g), Peptostreptococcaceae unclassified (s)
rs7594065 Firmicutes (p), Clostridia (c), Clostridiales (o), Clostridiales noname (f ),Pseudoflavonifractor (g)
rs10093096 Proteobacteria (p)
rs11545016 Firmicutes (p), Clostridia (c), Clostridiales (o), Lachnospiraceae (f ), Lachnospiraceae noname (g)
pathway
rs7585642 PWY-6060 (malonate degradation II, biotin-dependent)
rs131659 ARG+POLYAMINE-SYN (super pathway of arginine and polyamine biosynthesis)
rs11867190 PWY-3081 (L-lysine biosynthesis V)
GO
rs6848139 GO:0016831 (MF, carboxy-lyase activity)
p: phylum; c: class; o: order; f : family; g: genus; s: species.
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4. Discussion
To our knowledge, this work represented the first attempt to explore the interplay between host
genetics, gut microbiota, and CeD using a 2SMR approach. One of the key points for performing a
successful 2SMR analysis is the appropriate selection of datasets to be used as exposure and outcome.
In our study, instead of limiting the exposure data to selected instruments, we included the complete
summary statistics of the microbiome GWAS by Bonder and collaborators in our analysis, thus
increasing the coverage of our study. We then applied a stringent clumping protocol that selected
genome-wide significant and independent variants in 10,000 Kb windows, to end up with less than
3% of the genomic variants from the original datasets. In addition, compared to other genome-wide
studies on gut microbiome [8,9], the GWAS from Bonder and colleagues evaluates the contribution of
host genetics not only to bacterial composition but also in terms of functional units [10]. In fact, recent
whole-metagenome shotgun sequencing has revealed that fecal metabolic profiles are associated with
only a few key species but with many common microbial functions, stressing the importance of the
functional role of microbial communities on top of the microbial species present in the flora [27].
Regarding outcome data, we selected two breakthrough studies on CeD: the GWAS performed
by Dubois and collaborators was selected as a discovery dataset since it covered genetic variants
encompassing the whole genome [4]. As a “replication” dataset, we selected the celiac Immunochip
study that contains a smaller number of SNPs from regions known to be associated with immune
disorders but performs a much denser genotyping of those particular loci [3]. Despite the limited
overlap between the SNPs included in each of the two 2SMR analyses, eight out of the nine significant
associations from the discovery study were replicated, with similar effect sizes, underscoring the
validity of our results. On the other hand, the SNPs identified were located mainly in immune-related
loci, and this reinforced the idea that the host immune system plays a relevant role in shaping microbial
communities [28] also in the context of CeD.
In our analysis, we pinpointed a number of significant associations between host genetics, gut
microbiome, and CeD. One of the most interesting findings was that all the identified taxa-related SNPs
were linked to the Firmicutes and Proteobacteria phyla, two groups of bacteria whose abundance has
been shown to be altered in CeD patients that harbor HLA risk alleles [17,24,29–31]. In this sense, it has
been shown that Type I diabetes risk variants in the IL2 pathway genes are associated with microbial
shifts in mice and humans, including the decrease of the Lachnospiraceae and Clostridiales families of
the Firmicutes phylum [32]. Additionally, the oral administration of these particular strains is able
to reduce disease severity in mouse models of colitis and allergic diarrhea [33], possibly through a
bacteria-induced upregulation of ICOS and a consequent increased production of regulatory T-cells that
reduce exacerbated immune responses and inflammation. In the present work, we identified rs7594065
and rs6848139 (located close to the well-known interleukin-2 pathway genes—ICOS/CTLA4 and
IL-2—respectively) to be associated with both microbial features and CeD. In particular, the CeD-risk
allele of rs7594065 appeared to be negatively correlated with Clostridiales abundance. We proposed
that these SNPs somehow reduce the presence of ICOS and regulatory T cell-inducing strains in the
microbial flora, contributing to the characteristic inflammation of the celiac intestine.
Another SNP from the pathway category, namely rs131659, is associated with the bacterial
arginine/polyamine biosynthesis pathway. As illustrated in Figure 3a, the first step of this pathway
is the conversion of arginine to ornithine by arginase, an enzyme whose activity has been shown to
be induced by gluten peptides in human monocytes. In the second step, L-ornithine carboxy-lyase
(a GO-term that had also been identified in our analysis) transforms ornithine into polyamines, which
have been reported to increase permeability and inflammation in vitro [34]. Gluten peptides exert the
same level of activation of the arginine metabolism in CeD and healthy individuals [35], suggesting
that the increased activity of this pathway corresponds to the celiac microbiota and, in turn, causes
increased permeability and inflammation of the intestine.
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Figure 3. Schematic representation of the hypothetical mechanism of action of the identified
SNP-microbiota associations. (a) rs131659 is associated with increased bacterial arginine/polyamine
biosynthesis pathway, where arginine is converted to polyamines; by increasing permeability and
inflammation, polyamines could play a role in CeD manifestation. (b) rs11867190 SNP is associated
with CeD; increased production of L-lysine amino acid in the celiac intestine could be an adaptation of
gut bacteria to counteract the activity of type 2 transglutaminase (TG2), which converts glutamines into
glutamates; impaired TG2 activity would prevent the increase in the affinity of gliadin peptides for
HLA-DQ2/8 receptors. HLA, human leukocyte antigen.
The last example among our functional candidates is rs11867190, which is associated with increased
L-lysine biosynthesis (Figure 3b). A study carried out with gluten treated with transglutaminase type 2
(TG2) in th presence of a saturating amount of L-lysine has shown an interruption of the deamidation
reaction catalyzed by TG2 and, consequently, a lower affinity of these gluten-derived peptides for
HLA-DQ2 molecules. In fact, enzymatic modification of gluten with TG2 plus lysine has been able to
suppress its immunologic effects on the duodenal mucosa of CeD patients [36]. These data suggest
that a lysine-producing flora in CeD patients could represent a mechanism by which TG2 activity is
weakened as a response to the disease.
Nev rtheless, s me limitations of this study should also be c sidere . Our study used micr biome
data from a cohort of adult individuals, whereas several microbiome studies on CeD have been carried
out in children. It would be interesting to perform a similar analysis in an infant population when
genome-wide studies on childhood microbiota become available. Also, we cannot exclude the
possibility that non-significant associations might arise from a lack of power due to the limited sample
size (1514 individuals) of th microbiome GWAS. In this sense, the recently establishe MiBioGen
consortium aims to meta-analyze large-scale data fr m 18 independent cohorts in order to investigate
host genetics and microbiota associations in almost 20,000 subjects. This large-scale resource will also
be very useful to assess the biological impact of gene-microbiome interactions in different diseases,
including CeD [37]. Finally, the 2SMR approach cannot rule out the possibility that the associations
Nutrients 2020, 12, 1420 8 of 10
discovered are pleiotropic rather than causal, and even then, one cannot fully discard the possibility
of reverse causation. Actually, we proposed two opposite models: one in which variants associate
with CeD through the modification of bacterial arginine and polyamine synthesis and/or through the
reduction of regulatory T cell-inducing bacterial strains (direct causation), as well as another in which
SNPs are associated with CeD and the bacterial flora adapts to the pathological condition of the host by
producing lysine in an attempt to impair gliadin presentation by HLA molecules (reverse causation).
Further studies will certainly be needed in order to clarify this complex scenario.
In summary, this was the first work to identify genetic variants that could mediate CeD pathogenesis
through gut microbiota. Our results should be interpreted with caution, pending epidemiological and
experimental confirmation of the mechanisms proposed, but put forward interesting and plausible
hypotheses that can explain the complex interactions between the host and microbial communities
in the celiac gut, which might be potentially useful for the prediction, prevention, and treatment of
the disease.
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Figure S1: Schematic representation of 2SMR analysis using Bonder microbiome and Trynka CeD GWAS as
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